AUTHOR=Zhang Ziyan , Zhou Xiaomeng , Mei Ying , Bu Xiaoqing , Tang Jie , Gong Tao , Liu Guowei , Cai Shuwen , Ren Yanni , Mu Lihong 

TITLE=Novel low-sodium salt formulations combined with Chinese modified DASH diet for reducing blood pressure in patients with hypertension and type 2 diabetes: a clinical trial

JOURNAL=Frontiers in Nutrition

VOLUME=10

YEAR=2023

URL=https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1219381

DOI=10.3389/fnut.2023.1219381

ISSN=2296-861X

ABSTRACT=<sec id="sec1"><title>Background</title><p>In this study, we aimed to explore the antihypertensive effect of 23 and 52% concentrations of low-sodium salt combined with the Chinese Modified Dietary Approaches to Stop Hypertension (CM-DASH) diet in patients with hypertension and type 2 diabetes.</p></sec><sec id="sec2"><title>Methods</title><p>We conducted a randomized controlled single-blind trial with a semi-open design. One hundred and thirty-two participants were randomly assigned into Group A (control group), Group B (52% low-sodium salt group), Group C (23% low-sodium salt group), and Group D (meal pack group) for 8 weeks of dietary intervention. All participants were followed weekly to collect data on blood pressure, salt use, and adverse events. Blood and 24-h urine samples were analyzed at baseline, 4 weeks, and the end of the intervention.</p></sec><sec id="sec3"><title>Results</title><p>At the end of the intervention, the mean blood pressure decreased significantly by 10.81/5.03 mmHg, 14.32/6.32 mmHg, 14.20/6.59 mmHg, and 19.06/7.82 mmHg in Groups A–D, respectively, compared with baseline (<italic>p</italic> &lt; 0.001). Comparison between groups showed that the systolic blood pressure was lower in Groups C and D than in Groups A (−6.54 mmHg, −8.70 mmHg, <italic>p</italic> &lt; 0.05) and B (−6.60 mmHg, −8.76 mmHg, p &lt; 0.05), and the diastolic blood pressure was lower in Group D than in Group A (−5.17 mmHg, <italic>p</italic> = 0.006). The 24-h urinary Na<sup>+</sup> and Na<sup>+</sup>/K<sup>+</sup> values were significantly decreased in participants using low-sodium salt (<italic>p</italic> &lt; 0.001). No serious adverse events occurred during the trial.</p></sec><sec id="sec4"><title>Conclusion</title><p>Our preliminary results suggest that 23 and 52% concentrations of low-sodium salt combined with the CM-DASH diet can effectively reduce sodium intake and increase potassium intake in patients with hypertension and type 2 diabetes mellitus, thus achieving “salt reduction” and attaining standard, smooth, comprehensive management of patients with hypertension and type 2 diabetes.</p></sec><sec id="sec5"><title>Clinical trial registration</title><p><ext-link xlink:href="http://www.chictr.org.cn/" ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.chictr.org.cn/</ext-link>, ChiCTR2000029017.</p></sec>